No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients.

Source:http://linkedlifedata.com/resource/pubmed/id/10720082

Download in:

View as

General Info

PMID
10720082